OSLO, May 12 Norway will not resume the use of the Covid-19 vaccine made by AstraZeneca as part of its inoculation programme due to a risk of rare but harmful side-effects, newspaper VG reported today. Prime Minister Erna Solberg is expected to announce at 1600 GMT whether Norway will resume.
Norway has removed the vaccine against Covid-19 made by AstraZeneca from its inoculation campaign, Prime Minister Erna Solberg said. Solberg said on Wednesday that the decision was based on the advice of a committee of experts and the Norwegian Institute of Public Health (FHI), which recommended excluding the shots made by AstraZeneca and Johnson & Johnson due to the risk of very rare but serious side effects, DPA news agency reported.
Norway is also extending its temporary halt on the use of the Johnson & Johnson shot, but has not excluded it from its inoculation campaign for now, Solberg said. The government is currently looking into offering the Johnson & Johnson vaccine to those willing to receive it.
Norway will not resume the use of COVID-19 vaccines made by AstraZeneca, while a decision on whether to start using inoculations made by Johnson & Johnson\'s remains on hold, Prime Minister Erna Solberg said on Wednesday.
Related: New Zealand s Pfizer vaccine approval challenged in High Court. Credits: Video - Newshub; Image - Getty Images
A new global system should be set up to respond faster to disease outbreaks to help ensure no future virus causes a pandemic as devastating as COVID-19, an independent World Health Organization review panel led by former New Zealand Prime Minister Helen Clark said on Wednesday.
Here s the latest on the pandemic from around the world.
Europe
Germany
Germans desperate to be vaccinated against the coronavirus are becoming increasingly aggressive, doctors said on Wednesday, as frustration mounts after six months of lockdowns even though infection rates are now falling.
Norway will not resume usage of the AstraZeneca COVID-19 vaccine due to concerns about a blood-clotting issue that arose in some patients after taking the first dose, its prime minister is expected to announce.